Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities
10.2174/138920009790274531
Saved in:
Main Authors: | Chiu, G.N.C., Wong, M.-Y., Ling, L.-U., Shaikh, I.M., Tan, K.-B., Chaudhury, A., Tan, B.-J. |
---|---|
Other Authors: | PHARMACY |
Format: | Review |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106672 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Liposomal M-V-05: Formulation development and activity testing of a novel dihydrofolate reductase inhibitor for breast cancer therapy
by: Tan, B.J., et al.
Published: (2014) -
Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
by: Chiu, G.N.C., et al.
Published: (2014) -
DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012) -
The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo
by: Banno, B., et al.
Published: (2014) -
Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
by: Wang, J.-C., et al.
Published: (2011)